Current Cancer Drug Targets

Ruiwen Zhang 
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106
USA

Back

Editorial [Hot Topic: Overview of Antiangiogenic Therapies in Hematological Malignancies (Guest Editor: D. Ribatti)] promotion: free to download

Volume:11   Issue:9
Pp: 995-996
D. Ribatti
DOI: 10.2174/156800911798073087

Order Reprints Order Eprints

Cytokines as Anti-Angiogenic Agents in Haematological Malignancies

Volume:11   Issue:9
Pp: 997-1004
C. Cocco, E. Ferretti, I. Airoldi and V. Pistoia
DOI: 10.2174/156800911798073096

Order Reprints Order Eprints

Antiangiogenesis in Myelodysplastic Syndrome

Volume:11   Issue:9
Pp: 1044-1052
A. Aguayo, F. M. Armillas-Canseco and D. Martinez-Banos
DOI: 10.2174/156800911798073104

Order Reprints Order Eprints

EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors

Volume:11   Issue:9
Pp: 1082-1097
RONG Biao-xue, CAI Xi-guang, YANG Shuan-ying, LI Wei and MING Zong-juan
DOI: 10.2174/156800911798073050

Order Reprints Order Eprints

New Alkyl-Lipid Blockers of SK3 Channels Reduce Cancer Cell Migration and Occurrence of Metastasis

Volume:11   Issue:9
Pp: 1111-1125
A. Girault, J.-P. Haelters, M. Potier-Cartereau, A. Chantome, M. Pinault, S. Marionneau-Lambot, T. Oullier, G. Simon, H. Couthon-Gourves, P.-A. Jaffres, B. Corbel, P. Bougnoux, V. Joulin and C. Vandier
DOI: 10.2174/156800911798073069

Order Reprints Order Eprints